Marie T. Borin

1.1k total citations
43 papers, 775 citations indexed

About

Marie T. Borin is a scholar working on Pharmacology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Marie T. Borin has authored 43 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 11 papers in Infectious Diseases and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Marie T. Borin's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Marie T. Borin is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Marie T. Borin collaborates with scholars based in United States, France and Italy. Marie T. Borin's co-authors include George S. Hughes, William W. Freimuth, Giorgio Gatti, James W. Ayres, James R. White, John F. Flaherty, John G. Gambertoglio, Suzanne Gagnon, Joseph C. Fleishaker and Carter D. Brooks and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and International Journal of Pharmaceutics.

In The Last Decade

Marie T. Borin

41 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie T. Borin United States 17 302 208 202 130 108 43 775
Alfonso Domínguez‐Gil Spain 14 269 0.9× 279 1.3× 114 0.6× 49 0.4× 64 0.6× 26 863
Cyprian O. Onyeji Nigeria 17 218 0.7× 140 0.7× 157 0.8× 135 1.0× 69 0.6× 59 745
Klaus Borner Germany 16 392 1.3× 123 0.6× 222 1.1× 121 0.9× 107 1.0× 33 1.1k
Catherine A. Knupp United States 16 246 0.8× 273 1.3× 168 0.8× 133 1.0× 26 0.2× 20 619
Jan Sahai Canada 15 333 1.1× 532 2.6× 360 1.8× 62 0.5× 32 0.3× 35 1.1k
José Ramón Azanza Perea Spain 18 281 0.9× 276 1.3× 277 1.4× 84 0.6× 30 0.3× 108 1.2k
Ólanrewaju O. Okusanya United States 18 362 1.2× 153 0.7× 286 1.4× 352 2.7× 27 0.3× 38 845
Christophe Padoin France 13 236 0.8× 103 0.5× 123 0.6× 83 0.6× 27 0.3× 21 439
Sou-Yie Chu United States 14 260 0.9× 127 0.6× 260 1.3× 65 0.5× 34 0.3× 24 668
L. O. White United Kingdom 18 426 1.4× 100 0.5× 209 1.0× 217 1.7× 16 0.1× 33 749

Countries citing papers authored by Marie T. Borin

Since Specialization
Citations

This map shows the geographic impact of Marie T. Borin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie T. Borin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie T. Borin more than expected).

Fields of papers citing papers by Marie T. Borin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie T. Borin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie T. Borin. The network helps show where Marie T. Borin may publish in the future.

Co-authorship network of co-authors of Marie T. Borin

This figure shows the co-authorship network connecting the top 25 collaborators of Marie T. Borin. A scholar is included among the top collaborators of Marie T. Borin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie T. Borin. Marie T. Borin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lo, Arthur, Marie T. Borin, & David L. Bourdet. (2020). Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease. Clinical Pharmacokinetics. 60(3). 391–401.
2.
Borin, Marie T., Arthur Lo, Chris N. Barnes, Srikanth Pendyala, & David L. Bourdet. (2019). <p>Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function</p>. International Journal of COPD. Volume 14. 2305–2318. 5 indexed citations
3.
4.
Cass, Robert, et al.. (2011). Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 55(12). 5874–5880. 60 indexed citations
5.
Cox, Susan, et al.. (2009). Comparison of the Pharmacokinetics of Apricitabine in the Presence and Absence of Ritonavir-Boosted Tipranavir. Clinical Drug Investigation. 29(11). 721–728. 1 indexed citations
6.
Zhong, Wei-Zhu, Marta G. Williams, Marie T. Borin, & Guy E. Padbury. (1998). Species-dependent enantioselective pharmacokinetics of PNU-103017, a Pyrone HIV protease inhibitor. Chirality. 10(3). 210–216. 2 indexed citations
7.
Kearns, Gregory L., Susan M. Abdel‐Rahman, Richard F. Jacobs, Thomas G. Wells, & Marie T. Borin. (1998). Cefpodoxime pharmacokinetics in children: effect of food. The Pediatric Infectious Disease Journal. 17(9). 799–804. 15 indexed citations
8.
Borin, Marie T., et al.. (1997). Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate*. Clinical Pharmacology & Therapeutics. 61(5). 544–553. 49 indexed citations
9.
Borin, Marie T., et al.. (1997). Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients. Antiviral Research. 35(1). 53–63. 27 indexed citations
10.
Borin, Marie T., et al.. (1997). Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients. Antimicrobial Agents and Chemotherapy. 41(9). 1892–1897. 17 indexed citations
11.
Borin, Marie T., et al.. (1995). Effect of Timing of Food on Absorption of Cefpodoxime Proxetil. The Journal of Clinical Pharmacology. 35(5). 505–509. 8 indexed citations
12.
Borin, Marie T., et al.. (1994). Pharmacokinetics of Cefpodoxime Proxetil in Healthy Young and Elderly Volunteers. The Journal of Clinical Pharmacology. 34(7). 774–781. 8 indexed citations
13.
Johnson, Curtis A., S.W. Zimmerman, George S. Hughes, et al.. (1993). Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy. 37(12). 2650–2655. 5 indexed citations
14.
Borin, Marie T.. (1991). A Review of the Pharmacokinetics of Cefpodoxime Proxetil. Drugs. 42(Supplement 3). 13–21. 85 indexed citations
15.
Borin, Marie T., et al.. (1991). Pharmacokinetic and Tolerance Studies of Cefpodoxime after Single‐ and Multiple‐Dose Oral Administration of Cefpodoxime Proxetil. The Journal of Clinical Pharmacology. 31(12). 1137–1145. 27 indexed citations
16.
Skoug, John W., et al.. (1991). In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylate.. Pharmaceutical Research. 8(12). 1482–1488. 35 indexed citations
17.
Welage, Lynda S., et al.. (1990). Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole. Antimicrobial Agents and Chemotherapy. 34(12). 2369–2374. 11 indexed citations
18.
White, Joe L., et al.. (1989). In vitro adsorption of bile salts by colestipol hydrochloride.. Pharmaceutical Research. 6(7). 619–623. 9 indexed citations
19.
Borin, Marie T. & James W. Ayres. (1989). Single dose bioavailability of acetaminophen following oral administration. International Journal of Pharmaceutics. 54(3). 199–209. 28 indexed citations
20.
White, Joe L., et al.. (1989). Effect of anions on adsorption of bile salts by colestipol hydrochloride.. Pharmaceutical Research. 6(9). 794–797. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfonso Domínguez‐Gil Breakdown of academic impact, for papers by Cyprian O. Onyeji Breakdown of academic impact, for papers by Klaus Borner Breakdown of academic impact, for papers by Catherine A. Knupp Breakdown of academic impact, for papers by Jan Sahai Breakdown of academic impact, for papers by José Ramón Azanza Perea Breakdown of academic impact, for papers by Ólanrewaju O. Okusanya Breakdown of academic impact, for papers by Christophe Padoin Breakdown of academic impact, for papers by Sou-Yie Chu Breakdown of academic impact, for papers by L. O. White
Rankless by CCL
2026